Danish Study Reports Three Diabetes Drugs Best for Lowering Cardiovascular Risk

Cardiovascular Risk

| May 13, 2011

A Danish study of 107,806 adults taking various diabetes medications has found that three drugs are the most effective at lowering the risk of cardiovascular disease and death: metformin, gliclazide (not marketed in the US), and repaglinide (Prandin). Other common diabetes medications, including glimepiride, glibenclamide (glyburide), glipizide, and tolbutamide, were linked to a higher risk of death both from all causes and from heart attack and stroke.  

Researchers looked at the patients in the study group who had never had a cardiovascular event (9,607 had experienced a previous heart attack or stroke) to see which drugs might be more closely associated with a higher risk of death from all causes. They found that people taking glimepiride ran a 32 percent higher risk, while those taking glipizide ran a 27 percent higher risk, and those taking glibenclamide ran a 19 percent higher risk. People taking tolbutamide versus metformin ran a 28 percent higher risk of death.

The researchers reported that the risks were even higher for people taking these drugs who had experienced previous cardiovascular events.  

Previous research has shown that metformin reduces the risk of major cardiac events and death by about 40 percent compared to placebo. The Danish study showed that the risk profiles posed by gliclazide and repaglinide were about the same as metformin.

The drug classes of the above-named drugs include:
• Glibenclamide/Glyburide: sulfonylurea
• Gliclazide: sulfonylurea
• Glimepiride: sulfonylurea
• Glipizide: sulfonylurea
• Metformin: biguanide
• Replaginide: meglitinide (also "glinides")
• Tolbutamide: sulfonylurea

The researchers cautioned people with diabetes to consult with their doctors if they are concerned about potential dangers from the drugs they're taking. Unilaterally ceasing prescribed medications could be dangerous.

Results of the study were published online in the European Heart Journal.

Click Here To View Or Post Comments

Categories: , Complications & Care, Diabetes, Diabetes, Glyburide, Heart Disease, Medications Research, Metformin, Prandin, sulfonylurea


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • What's on the Horizon with Diabetes Research and Therapy
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated
Print | Email | Share | Comments (1)

You May Also Be Interested In...


Comments

Posted by Steve Parker, M.D. on 14 May 2011

This is incredibly important information, given the millions worldwide taking these drugs. I'll get a copy of the article and review it at my diabetes blog soon.

-Steve


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...


Username: Password:
Comment:
©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.